AwardedDNKGoods
Rammeaftale om køb af Breyanzi (lisocabtagene maraleucel)
- Published
- Published 15 May 2025
Overview
Formålet med rammeaftalen er at kunne forsyne sygehusapotekerne hos Amgros' interessenter med lægemidlet Breyanzi (lisocabtagene maraleucel). Region Hovedstadens sygehusapotek foretager endvidere indkøb med henblik på videresalg Grønland og Færøerne.
Key details
- Country
- DNK
- Status
- Awarded
- Category
- Goods
- Procedure
- Direct
- Published
- 15 May 2025
Pharmaceutical products
Award outcome
- Awarded value
- DKK 1
- Award date
- 15 August 2025
- Contract period
- 15 August 2025 → 31 July 2029
- Bristol-Myers Squibb Denmark. Filial Af Bristol-Myers Squibb AB. Sverige
Contract ending soon? Skim tracks incumbents and flags recompetes early. Book a demo to set up alerts.
Notice history
Every published notice in this contracting process, newest first.
Contract Award Notice
9 March 2026
Contract Notice
15 May 2025
Contracting authority
Amgros I/S
Procuring entityKøbenhavn Ø, DNK
Authority website ↗
Get the full picture
AI analysis, bid scoring, and expert strategy for this tender
Skim analyses every tender against your company profile and tells you whether to bid, how to win, and who you are up against.
See which competitors are winning the contracts you're chasing.
15-minute call. We'll pull the win data on your real pipeline and show you what Skim does with it.